2018-2023 Global Psoriasis Drug Consumption Market Report

August 2018 | 164 pages | ID: 23F85B562A7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Psoriasis Drug market for 2018-2023.
Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.

Over the next five years, LPI(LP Information) projects that Psoriasis Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Psoriasis Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• External Use
• Oral
• Injection

Segmentation by application:

• Hospital
• Drugs Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• AbbVie
• Johnson & Johnson
• Bayer
• Galderma
• Bristol-Myers Squibb
• Novartis
• Pfizer
• Merz Pharma
• Valeant
• LEO Pharma
• GlaxoSmithKline

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Psoriasis Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Psoriasis Drug market by identifying its various subsegments.
• Focuses on the key global Psoriasis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Psoriasis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Psoriasis Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL PSORIASIS DRUG CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Psoriasis Drug Consumption 2013-2023
  2.1.2 Psoriasis Drug Consumption CAGR by Region
2.2 Psoriasis Drug Segment by Type
  2.2.1 External Use
  2.2.2 Oral
  2.2.3 Injection
2.3 Psoriasis Drug Consumption by Type
  2.3.1 Global Psoriasis Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Psoriasis Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Psoriasis Drug Sale Price by Type (2013-2018)
2.4 Psoriasis Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
2.5 Psoriasis Drug Consumption by Application
  2.5.1 Global Psoriasis Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Psoriasis Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Psoriasis Drug Sale Price by Application (2013-2018)

3 GLOBAL PSORIASIS DRUG BY PLAYERS

3.1 Global Psoriasis Drug Sales Market Share by Players
  3.1.1 Global Psoriasis Drug Sales by Players (2016-2018)
  3.1.2 Global Psoriasis Drug Sales Market Share by Players (2016-2018)
3.2 Global Psoriasis Drug Revenue Market Share by Players
  3.2.1 Global Psoriasis Drug Revenue by Players (2016-2018)
  3.2.2 Global Psoriasis Drug Revenue Market Share by Players (2016-2018)
3.3 Global Psoriasis Drug Sale Price by Players
3.4 Global Psoriasis Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Psoriasis Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Psoriasis Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PSORIASIS DRUG BY REGIONS

4.1 Psoriasis Drug by Regions
  4.1.1 Global Psoriasis Drug Consumption by Regions
  4.1.2 Global Psoriasis Drug Value by Regions
4.2 Americas Psoriasis Drug Consumption Growth
4.3 APAC Psoriasis Drug Consumption Growth
4.4 Europe Psoriasis Drug Consumption Growth
4.5 Middle East & Africa Psoriasis Drug Consumption Growth

5 AMERICAS

5.1 Americas Psoriasis Drug Consumption by Countries
  5.1.1 Americas Psoriasis Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Psoriasis Drug Value by Countries (2013-2018)
5.2 Americas Psoriasis Drug Consumption by Type
5.3 Americas Psoriasis Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Psoriasis Drug Consumption by Countries
  6.1.1 APAC Psoriasis Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Psoriasis Drug Value by Countries (2013-2018)
6.2 APAC Psoriasis Drug Consumption by Type
6.3 APAC Psoriasis Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Psoriasis Drug by Countries
  7.1.1 Europe Psoriasis Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Psoriasis Drug Value by Countries (2013-2018)
7.2 Europe Psoriasis Drug Consumption by Type
7.3 Europe Psoriasis Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Psoriasis Drug by Countries
  8.1.1 Middle East & Africa Psoriasis Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Psoriasis Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Psoriasis Drug Consumption by Type
8.3 Middle East & Africa Psoriasis Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Psoriasis Drug Distributors
10.3 Psoriasis Drug Customer

11 GLOBAL PSORIASIS DRUG MARKET FORECAST

11.1 Global Psoriasis Drug Consumption Forecast (2018-2023)
11.2 Global Psoriasis Drug Forecast by Regions
  11.2.1 Global Psoriasis Drug Forecast by Regions (2018-2023)
  11.2.2 Global Psoriasis Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Psoriasis Drug Forecast by Type
11.8 Global Psoriasis Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AbbVie
  12.1.1 Company Details
  12.1.2 Psoriasis Drug Product Offered
  12.1.3 AbbVie Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AbbVie News
12.2 Johnson & Johnson
  12.2.1 Company Details
  12.2.2 Psoriasis Drug Product Offered
  12.2.3 Johnson & Johnson Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Johnson & Johnson News
12.3 Bayer
  12.3.1 Company Details
  12.3.2 Psoriasis Drug Product Offered
  12.3.3 Bayer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bayer News
12.4 Galderma
  12.4.1 Company Details
  12.4.2 Psoriasis Drug Product Offered
  12.4.3 Galderma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Galderma News
12.5 Bristol-Myers Squibb
  12.5.1 Company Details
  12.5.2 Psoriasis Drug Product Offered
  12.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Bristol-Myers Squibb News
12.6 Novartis
  12.6.1 Company Details
  12.6.2 Psoriasis Drug Product Offered
  12.6.3 Novartis Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Novartis News
12.7 Pfizer
  12.7.1 Company Details
  12.7.2 Psoriasis Drug Product Offered
  12.7.3 Pfizer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Pfizer News
12.8 Merz Pharma
  12.8.1 Company Details
  12.8.2 Psoriasis Drug Product Offered
  12.8.3 Merz Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Merz Pharma News
12.9 Valeant
  12.9.1 Company Details
  12.9.2 Psoriasis Drug Product Offered
  12.9.3 Valeant Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Valeant News
12.10 LEO Pharma
  12.10.1 Company Details
  12.10.2 Psoriasis Drug Product Offered
  12.10.3 LEO Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 LEO Pharma News
12.11 GlaxoSmithKline

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Psoriasis Drug
Table Product Specifications of Psoriasis Drug
Figure Psoriasis Drug Report Years Considered
Figure Market Research Methodology
Figure Global Psoriasis Drug Consumption Growth Rate 2013-2023 (K Units)
Figure Global Psoriasis Drug Value Growth Rate 2013-2023 ($ Millions)
Table Psoriasis Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of External Use
Table Major Players of External Use
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Injection
Table Major Players of Injection
Table Global Consumption Sales by Type (2013-2018)
Table Global Psoriasis Drug Consumption Market Share by Type (2013-2018)
Figure Global Psoriasis Drug Consumption Market Share by Type (2013-2018)
Table Global Psoriasis Drug Revenue by Type (2013-2018) ($ million)
Table Global Psoriasis Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Psoriasis Drug Value Market Share by Type (2013-2018)
Table Global Psoriasis Drug Sale Price by Type (2013-2018)
Figure Psoriasis Drug Consumed in Hospital
Figure Global Psoriasis Drug Market: Hospital (2013-2018) (K Units)
Figure Global Psoriasis Drug Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Psoriasis Drug Consumed in Drugs Store
Figure Global Psoriasis Drug Market: Drugs Store (2013-2018) (K Units)
Figure Global Psoriasis Drug Market: Drugs Store (2013-2018) ($ Millions)
Figure Global Drugs Store YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Psoriasis Drug Consumption Market Share by Application (2013-2018)
Figure Global Psoriasis Drug Consumption Market Share by Application (2013-2018)
Table Global Psoriasis Drug Value by Application (2013-2018)
Table Global Psoriasis Drug Value Market Share by Application (2013-2018)
Figure Global Psoriasis Drug Value Market Share by Application (2013-2018)
Table Global Psoriasis Drug Sale Price by Application (2013-2018)
Table Global Psoriasis Drug Sales by Players (2016-2018) (K Units)
Table Global Psoriasis Drug Sales Market Share by Players (2016-2018)
Figure Global Psoriasis Drug Sales Market Share by Players in 2016
Figure Global Psoriasis Drug Sales Market Share by Players in 2017
Table Global Psoriasis Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Psoriasis Drug Revenue Market Share by Players (2016-2018)
Figure Global Psoriasis Drug Revenue Market Share by Players in 2016
Figure Global Psoriasis Drug Revenue Market Share by Players in 2017
Table Global Psoriasis Drug Sale Price by Players (2016-2018)
Figure Global Psoriasis Drug Sale Price by Players in 2017
Table Global Psoriasis Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Psoriasis Drug Products Offered
Table Psoriasis Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Psoriasis Drug Consumption by Regions 2013-2018 (K Units)
Table Global Psoriasis Drug Consumption Market Share by Regions 2013-2018
Figure Global Psoriasis Drug Consumption Market Share by Regions 2013-2018
Table Global Psoriasis Drug Value by Regions 2013-2018 ($ Millions)
Table Global Psoriasis Drug Value Market Share by Regions 2013-2018
Figure Global Psoriasis Drug Value Market Share by Regions 2013-2018
Figure Americas Psoriasis Drug Consumption 2013-2018 (K Units)
Figure Americas Psoriasis Drug Value 2013-2018 ($ Millions)
Figure APAC Psoriasis Drug Consumption 2013-2018 (K Units)
Figure APAC Psoriasis Drug Value 2013-2018 ($ Millions)
Figure Europe Psoriasis Drug Consumption 2013-2018 (K Units)
Figure Europe Psoriasis Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Psoriasis Drug Consumption 2013-2018 (K Units)
Figure Middle East & Africa Psoriasis Drug Value 2013-2018 ($ Millions)
Table Americas Psoriasis Drug Consumption by Countries (2013-2018) (K Units)
Table Americas Psoriasis Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Psoriasis Drug Consumption Market Share by Countries in 2017
Table Americas Psoriasis Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Psoriasis Drug Value Market Share by Countries (2013-2018)
Figure Americas Psoriasis Drug Value Market Share by Countries in 2017
Table Americas Psoriasis Drug Consumption by Type (2013-2018) (K Units)
Table Americas Psoriasis Drug Consumption Market Share by Type (2013-2018)
Figure Americas Psoriasis Drug Consumption Market Share by Type in 2017
Table Americas Psoriasis Drug Consumption by Application (2013-2018) (K Units)
Table Americas Psoriasis Drug Consumption Market Share by Application (2013-2018)
Figure Americas Psoriasis Drug Consumption Market Share by Application in 2017
Figure United States Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure United States Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Canada Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Mexico Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Table APAC Psoriasis Drug Consumption by Countries (2013-2018) (K Units)
Table APAC Psoriasis Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Psoriasis Drug Consumption Market Share by Countries in 2017
Table APAC Psoriasis Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Psoriasis Drug Value Market Share by Countries (2013-2018)
Figure APAC Psoriasis Drug Value Market Share by Countries in 2017
Table APAC Psoriasis Drug Consumption by Type (2013-2018) (K Units)
Table APAC Psoriasis Drug Consumption Market Share by Type (2013-2018)
Figure APAC Psoriasis Drug Consumption Market Share by Type in 2017
Table APAC Psoriasis Drug Consumption by Application (2013-2018) (K Units)
Table APAC Psoriasis Drug Consumption Market Share by Application (2013-2018)
Figure APAC Psoriasis Drug Consumption Market Share by Application in 2017
Figure China Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure China Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Japan Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Korea Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure India Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure India Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Australia Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Table Europe Psoriasis Drug Consumption by Countries (2013-2018) (K Units)
Table Europe Psoriasis Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Psoriasis Drug Consumption Market Share by Countries in 2017
Table Europe Psoriasis Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Psoriasis Drug Value Market Share by Countries (2013-2018)
Figure Europe Psoriasis Drug Value Market Share by Countries in 2017
Table Europe Psoriasis Drug Consumption by Type (2013-2018) (K Units)
Table Europe Psoriasis Drug Consumption Market Share by Type (2013-2018)
Figure Europe Psoriasis Drug Consumption Market Share by Type in 2017
Table Europe Psoriasis Drug Consumption by Application (2013-2018) (K Units)
Table Europe Psoriasis Drug Consumption Market Share by Application (2013-2018)
Figure Europe Psoriasis Drug Consumption Market Share by Application in 2017
Figure Germany Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Germany Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure France Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure France Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure UK Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure UK Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Italy Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Russia Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Spain Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Psoriasis Drug Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Psoriasis Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Psoriasis Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Psoriasis Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Psoriasis Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Psoriasis Drug Value Market Share by Countries in 2017
Table Middle East & Africa Psoriasis Drug Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Psoriasis Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Psoriasis Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Psoriasis Drug Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Psoriasis Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Psoriasis Drug Consumption Market Share by Application in 2017
Figure Egypt Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Egypt Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure South Africa Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Israel Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure Turkey Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Psoriasis Drug Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Psoriasis Drug Value Growth 2013-2018 ($ Millions)
Table Psoriasis Drug Distributors List
Table Psoriasis Drug Customer List
Figure Global Psoriasis Drug Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Psoriasis Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Psoriasis Drug Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Psoriasis Drug Consumption Market Forecast by Regions
Table Global Psoriasis Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Psoriasis Drug Value Market Share Forecast by Regions
Figure Americas Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Americas Psoriasis Drug Value 2018-2023 ($ Millions)
Figure APAC Psoriasis Drug Consumption 2018-2023 (K Units)
Figure APAC Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Europe Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Europe Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Middle East & Africa Psoriasis Drug Value 2018-2023 ($ Millions)
Figure United States Psoriasis Drug Consumption 2018-2023 (K Units)
Figure United States Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Canada Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Canada Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Mexico Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Mexico Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Brazil Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Brazil Psoriasis Drug Value 2018-2023 ($ Millions)
Figure China Psoriasis Drug Consumption 2018-2023 (K Units)
Figure China Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Japan Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Japan Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Korea Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Korea Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Southeast Asia Psoriasis Drug Value 2018-2023 ($ Millions)
Figure India Psoriasis Drug Consumption 2018-2023 (K Units)
Figure India Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Australia Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Australia Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Germany Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Germany Psoriasis Drug Value 2018-2023 ($ Millions)
Figure France Psoriasis Drug Consumption 2018-2023 (K Units)
Figure France Psoriasis Drug Value 2018-2023 ($ Millions)
Figure UK Psoriasis Drug Consumption 2018-2023 (K Units)
Figure UK Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Italy Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Italy Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Russia Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Russia Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Spain Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Spain Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Egypt Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Egypt Psoriasis Drug Value 2018-2023 ($ Millions)
Figure South Africa Psoriasis Drug Consumption 2018-2023 (K Units)
Figure South Africa Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Israel Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Israel Psoriasis Drug Value 2018-2023 ($ Millions)
Figure Turkey Psoriasis Drug Consumption 2018-2023 (K Units)
Figure Turkey Psoriasis Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Psoriasis Drug Consumption 2018-2023 (K Units)
Figure GCC Countries Psoriasis Drug Value 2018-2023 ($ Millions)
Table Global Psoriasis Drug Consumption Forecast by Type (2018-2023) (K Units)
Table Global Psoriasis Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Psoriasis Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Psoriasis Drug Value Market Share Forecast by Type (2018-2023)
Table Global Psoriasis Drug Consumption Forecast by Application (2018-2023) (K Units)
Table Global Psoriasis Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Psoriasis Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Psoriasis Drug Value Market Share Forecast by Application (2018-2023)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Psoriasis Drug Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Psoriasis Drug Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Psoriasis Drug Market Share (2016-2018)
Table Galderma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galderma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Galderma Psoriasis Drug Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Psoriasis Drug Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Psoriasis Drug Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Psoriasis Drug Market Share (2016-2018)
Table Merz Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merz Pharma Psoriasis Drug Market Share (2016-2018)
Table Valeant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Psoriasis Drug Market Share (2016-2018)
Table LEO Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LEO Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure LEO Pharma Psoriasis Drug Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors